Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 376

The DOI matches its Crossref record.

Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up

Gagnon, David R., Zhang, Ting-Jie, Brand, Frederick N., Kannel, William B.·1994·American Heart Journal
DOI 10.1016/0002-8703(94)90679-3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0002-8703(94)90679-3

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Elwood, 1974, Mortality and anaemia in women, Lancet, 1, 891, 10.1016/S0140-6736(74)90346-8 · DOI
  2. Sorlie, 1981, Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program, Am Heart J, 101, 456, 10.1016/0002-8703(81)90136-8 · DOI
  3. Lowe, 1981, Blood rheology and thrombosis, Clin Haematol, 10, 343, 10.1016/S0308-2261(21)00228-9 · DOI
  4. Carter, 1983, Hematocrit and the risk of coronary heart disease, Am Heart J, 105, 674, 10.1016/0002-8703(83)90493-3 · DOI
  5. Lowe, 1980, Relation between extent of coronary artery disease and blood viscosity, Br Med J, 1, 673, 10.1136/bmj.280.6215.673 · DOI · Paper page
  6. Nicolaides, 1977, Blood viscosity, red-cell flexibility, hematocrit, and plasma-fibrinogen in patients with angina, Lancet, 2, 943, 10.1016/S0140-6736(77)90886-8 · DOI
  7. Tohgi, 1978, Importance of the hematocrit as a risk factor in cerebral infarction, Stroke, 9, 369, 10.1161/01.STR.9.4.369 · DOI
  8. Thomas, 1977, Effect of hematocrit on cerebral blood-flow in man, Lancet, 2, 941, 10.1016/S0140-6736(77)90885-6 · DOI · Paper page
  9. Kiyohara, 1986, Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community, Stroke, 17, 687, 10.1161/01.STR.17.4.687 · DOI
  10. Lowe, 1983, Relation of atrial fibrillation and high hematocrit to mortality in acute stroke, Lancet, 1, 784, 10.1016/S0140-6736(83)91848-2 · DOI
  11. Harrison, 1981, Effect of hematocrit on carotoid stenosis and cerebral infarction, Lancet, 2, 114, 10.1016/S0140-6736(81)90298-1 · DOI
  12. Kannel, 1972, Hemoglobin and the risk on cerebral infarction: the Framingham Study, Stroke, 3, 409, 10.1161/01.STR.3.4.409 · DOI · Paper page
  13. Wood, 1985, Hemorheology of the cerebral circulation in stroke, Stroke, 16, 765, 10.1161/01.STR.16.5.765 · DOI
  14. Dormandy, 1973, Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication, Br Med J, 4, 576, 10.1136/bmj.4.5892.576 · DOI · Paper page
  15. Dormandy, 1974, Effect of clofibrate on blood viscosity in intermittent claudication, Br Med J, 4, 259, 10.1136/bmj.4.5939.259 · DOI
  16. Kannel, 1987, Fibrinogen, cigarette smoking and risk of cardiovascular disease: insights from the Framingham Study, Am Heart J, 118, 1006, 10.1016/0002-8703(87)90063-9 · DOI · Paper page
  17. Kannel, 1987, Fibrinogen and risk of cardiovascular disease, JAMA, 2587, 1183, 10.1001/jama.1987.03400090067035 · DOI · Paper page
  18. Lowe, 1985, Platelet aggregation, haematocrit, and fibrinogen, Lancet, 1, 395, 10.1016/S0140-6736(85)91414-X · DOI
  19. Harrison, 1984, Haematocrit and platelet aggregation, Lancet, 2, 991, 10.1016/S0140-6736(84)91216-9 · DOI
  20. Wade, 1987, Hemoglobin concentration and prognosis in symptomatic obstructive cerebrovascular disease, Stroke, 18, 68, 10.1161/01.STR.18.1.68 · DOI
  21. Maizelaar, 1986, Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike, Stroke, 17, 44, 10.1161/01.STR.17.1.44 · DOI
  22. Cohn, 1984, Hematocrit and coronary heart disease, Am Heart J, 107, 186, 10.1016/0002-8703(84)90161-3 · DOI
  23. Lockwood, 1981, Blood donation and risk of cardiovascular disease, Lancet, 2, 1424, 10.1016/S0140-6736(81)92602-7 · DOI
  24. Bruch, 1979, Of bloodletting, Am Heart J, 98, 666, 10.1016/0002-8703(79)90295-3 · DOI
  25. Dawber, 1957, Coronary heart disease in Framingham Study., Am J Public Health, 47, 4, 10.2105/AJPH.47.4_Pt_2.4 · DOI · Paper page
  26. Gordon, 1959, Some methodologic problem in the long-term study of cardiovascular disease: observations from the Framingham Study, J Chronic Dis, 10, 186, 10.1016/0021-9681(59)90002-5 · DOI
  27. Cupples, 1988, Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study, Stat Med, 7, 205, 10.1002/sim.4780070122 · DOI · Paper page
  28. Li, 1992, A randomized control trial of isovolemic hemodilution therapy in cor pulmonale, Chin J Intern Med, 23, 339
  29. Zhange, 1983, A study on hemorheology in cerebrovascular disease, Chin J Intern Med, 22, 465
  30. Lawrence, 1953, Nature and treatment of polycythemia; study on 263 patients, Medicine, 32, 323, 10.1097/00005792-195309000-00002 · DOI
  31. Videbaeck, 1950, Polythemia vera: course and prognosis, Acta Med Scand, 138, 179, 10.1111/j.0954-6820.1950.tb10111.x · DOI
  32. Kershenovich, 1992, Markedly decreased coronary blood flow in secondary pplycythemia, Am Heart J, 123, 521, 10.1016/0002-8703(92)90671-H · DOI
  33. Burge, 1975, Morbidity and mortality in pseudopolycythemia, Lancet, 1, 1266, 10.1016/S0140-6736(75)92551-9 · DOI
  34. Pearson, 1978, Vascular occlusive episodes and venous hematocrit in primary proliferate polycythemia, Lancet, 2, 1219, 10.1016/S0140-6736(78)92098-6 · DOI · Paper page
  35. Dormandy, 1973, Prognostic significance of rheological and biochemical findings in patient with intermittent claudication, Br Med J, 4, 581, 10.1136/bmj.4.5892.581 · DOI
  36. Kannel, 1987, Fibrinogen and risk of cardiovascular disease: the Framingham Study, JAMA, 258, 1183, 10.1001/jama.1987.03400090067035 · DOI · Paper page
  37. Stokes, 1987, The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study, Circulation, 75, 1165
  38. Siekert, 1960, Anemia and intermittent focal cerebral arterial insufficiency, Arch Neurol, 3, 386, 10.1001/archneur.1960.00450040036004 · DOI
  39. Knizley, 1972, Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis, Arch Intern Med, 129, 483, 10.1001/archinte.1972.00320030103013 · DOI
  40. Iso, 1989, Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial, N Engl J Med, 320, 904, 10.1056/NEJM198904063201405 · DOI · Paper page

Cited by

See all 376

Metadata

Authors
Gagnon, D. R., Zhang, T.-J., Brand, F. N., & Kannel, W. B.
Venue
American Heart Journal
Publisher
Elsevier BV
Published
1994-03
Volume
127
Issue
3
Pages
674-682
ISSN
0002-8703 (ISSN-L)
DOI
10.1016/0002-8703(94)90679-3
OpenAlex
W2073652617
Cited by
376
References
0
FWCI
3.24
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up. https://app.cochat.ai/papers/10.1016/0002-8703(94)90679-3
The paper
Gagnon, D. R., Zhang, T.-J., Brand, F. N., & Kannel, W. B. (1994). Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up. American Heart Journal. https://doi.org/10.1016/0002-8703(94)90679-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.